Erik Fenster

Person

San Bruno, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Neprilysin inhibitors
- Patent number 12,016,835
- Issue date Jun 25, 2024
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrimidine pyridinone compounds as JAK inhibitors
- Patent number 11,697,648
- Issue date Jul 11, 2023
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,642,332
- Issue date May 9, 2023
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Substituted pyridines and methods of use
- Patent number 11,590,116
- Issue date Feb 28, 2023
- Theravance Biopharma R&D IP, LLC
- Christina Owens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,547,687
- Issue date Jan 10, 2023
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
- Patent number 11,339,160
- Issue date May 24, 2022
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,033,533
- Issue date Jun 15, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,968,205
- Issue date Apr 6, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
- Patent number 10,851,102
- Issue date Dec 1, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,744,104
- Issue date Aug 18, 2020
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,548,879
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,538,513
- Issue date Jan 21, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,392,368
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,172,834
- Issue date Jan 8, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,123,984
- Issue date Nov 13, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,053,417
- Issue date Aug 21, 2018
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 9,872,855
- Issue date Jan 23, 2018
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,868,698
- Issue date Jan 16, 2018
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,840,460
- Issue date Dec 12, 2017
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,688,616
- Issue date Jun 27, 2017
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,682,052
- Issue date Jun 20, 2017
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,670,143
- Issue date Jun 6, 2017
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 9,533,962
- Issue date Jan 3, 2017
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...
- Patent number 9,433,598
- Issue date Sep 6, 2016
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,428,457
- Issue date Aug 30, 2016
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,150,500
- Issue date Oct 6, 2015
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,096,496
- Issue date Aug 4, 2015
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 8,901,169
- Issue date Dec 2, 2014
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 8,691,868
- Issue date Apr 8, 2014
- Theravance, Inc.
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20230285340
- Publication date Sep 14, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDINES AND METHODS OF USE
- Publication number 20230218597
- Publication date Jul 13, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- Christina Owens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20220119369
- Publication date Apr 21, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20210401808
- Publication date Dec 30, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS
- Publication number 20210188844
- Publication date Jun 24, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDINES AND METHODS OF USE
- Publication number 20210154179
- Publication date May 27, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Christina Owens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20210059966
- Publication date Mar 4, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS
- Publication number 20210040085
- Publication date Feb 11, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20200281900
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS
- Publication number 20200231590
- Publication date Jul 23, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200216423
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190315724
- Publication date Oct 17, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20190269659
- Publication date Sep 5, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20190262297
- Publication date Aug 29, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190040043
- Publication date Feb 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ERIK FENSTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20180228774
- Publication date Aug 16, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20180194718
- Publication date Jul 12, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20170368010
- Publication date Dec 28, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...
- Publication number 20170355665
- Publication date Dec 14, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20170327459
- Publication date Nov 16, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20170196841
- Publication date Jul 13, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...
- Publication number 20170088508
- Publication date Mar 30, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20170015619
- Publication date Jan 19, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20160244416
- Publication date Aug 25, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...
- Publication number 20160228395
- Publication date Aug 11, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20160074352
- Publication date Mar 17, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20150376128
- Publication date Dec 31, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20150166469
- Publication date Jun 18, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20140343138
- Publication date Nov 20, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20140256702
- Publication date Sep 11, 2014
- Theravance, Inc.
- Erik Fenster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Erik Fenster

Person

Patents Grantslast 30 patents

Neprilysin inhibitors

Fused pyrimidine pyridinone compounds as JAK inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Substituted pyridines and methods of use

Neprilysin inhibitors

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-...

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Patents Applicationslast 30 patents

NEPRILYSIN INHIBITORS

SUBSTITUTED PYRIDINES AND METHODS OF USE

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS

SUBSTITUTED PYRIDINES AND METHODS OF USE

NEPRILYSIN INHIBITORS

IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

NEPRILYSIN INHIBITORS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-...

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS